Revolution Medicines, Inc.
Hedge Funds Holdings
Last updated:
Revolution Medicines, Inc.‘s stocks are currently a part of 84 hedge funds’ portfolios, which represents 47.24% of the total amount of its stocks outstanding. This makes up a total of 38.08M shares of Revolution Medicines, Inc.. Compared to the previous quarter, the number fell by -56.91% or -50.30M shares fewer. As for the holding position changes, 51.19% (43) of current hedge fund investors increased the number of shares held, 19.05% (16) of current holders sold a part of the shares held, and 10.71% (9) closed the holdings completely. 18 hedge funds are new holders of Revolution Medicines, Inc. stock in Q1 2023, it is 21.43% of total holders.
Hedge funds holding Revolution Medicines (Q4 2017 – Q1 2023)
| Q4 2017 | 2 |
|---|---|
| Q1 2018 | 2 |
| Q2 2018 | 2 |
| Q3 2018 | 2 |
| Q4 2018 | 1 |
| Q1 2019 | 1 |
| Q2 2019 | 0 |
| Q1 2020 | 73 |
| Q2 2020 | 75 |
| Q3 2020 | 90 |
| Q4 2020 | 118 |
| Q1 2021 | 125 |
| Q2 2021 | 128 |
| Q3 2021 | 110 |
| Q4 2021 | 113 |
| Q1 2022 | 122 |
| Q2 2022 | 126 |
| Q3 2022 | 135 |
| Q4 2022 | 134 |
| Q1 2023 | 84 |
Hedge funds changes in Revolution Medicines positions (Q4 2017 – Q1 2023)
| Q4 2017 | 0 | 2 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2018 | 0 | 1 | 1 | 0 | 0 |
| Q2 2018 | 0 | 0 | 1 | 0 | 1 |
| Q3 2018 | 0 | 2 | 0 | 0 | 0 |
| Q4 2018 | 0 | 0 | 1 | 1 | -1 |
| Q1 2019 | 0 | 0 | 1 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 1 | -1 |
| Q1 2020 | 73 | 0 | 0 | 0 | 0 |
| Q2 2020 | 19 | 24 | 16 | 17 | -1 |
| Q3 2020 | 25 | 39 | 11 | 10 | 5 |
| Q4 2020 | 41 | 37 | 22 | 12 | 6 |
| Q1 2021 | 27 | 51 | 23 | 20 | 4 |
| Q2 2021 | 21 | 63 | 19 | 18 | 7 |
| Q3 2021 | 10 | 38 | 29 | 27 | 6 |
| Q4 2021 | 18 | 39 | 28 | 14 | 14 |
| Q1 2022 | 17 | 42 | 33 | 7 | 23 |
| Q2 2022 | 20 | 40 | 38 | 12 | 16 |
| Q3 2022 | 21 | 73 | 21 | 14 | 6 |
| Q4 2022 | 22 | 50 | 39 | 20 | 3 |
| Q1 2023 | 18 | 43 | 16 | 9 | -2 |
Hedge funds changes in Revolution Medicines stock options (Q4 2017 – Q1 2023)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 23,000 | 0 |
| Q1 2021 | 9,602,000 | 404,000 |
| Q2 2021 | 1,511,000 | 1,298,000 |
| Q3 2021 | 1,583,000 | 1,605,000 |
| Q4 2021 | 2,280,000 | 1,273,000 |
| Q1 2022 | 3,216,000 | 1,167,000 |
| Q2 2022 | 901,000 | 488,000 |
| Q3 2022 | 3,882,000 | 1,481,000 |
| Q4 2022 | 3,849,266 | 747,948 |
| Q1 2023 | 2,235,000 | 15,248,000 |